Background illustration for clinical trials search

Paid Clinical Trials Plano

Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Dallas TX, Lewisville TX, Mansfield TX, Fort Worth TX,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07231419

Phase 3, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Dallas TX, Waco TX, Round Rock TX, San Antonio TX,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT06628908

Phase 3, Recruiting
Active & Responsive

Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis

for
Knee Cartilage Defects
Location: Dallas TX, Houston TX, San Antonio TX, Kenner LA,
Sponsor: Medipost, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07339111

Phase 3, Recruiting
Active & Responsive

Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

for
Smoking Cessation
Location: Dallas TX, Fort Worth TX, Austin TX, Huston TX,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT07766655

Phase 3, Recruiting
Active & Responsive

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

for
Elevated Blood Pressure, Hypertension
Location: Dallas TX, Houston TX, Bowling Green KY, Cleveland TN,
Sponsor: Zona Health, Inc

Sex: All

Age: 22+

Code: NCT06843577

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

for
Type 2 Diabetes Mellitus
Location: Dallas TX, Paris TX, Little Rock AR, Ridgeland MS,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07662109

Phase 3, Recruiting
Active & Responsive

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Dallas TX, Fort Worth TX, Oklahoma City OK, Austin TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting
Active & Responsive

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

for
Obesity, Overweight
Location: Dallas TX, Bellaire TX, San Antonio TX, Lake Charles LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07321886

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Dallas TX, DeSoto TX, Austin TX, Tomball TX,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07816367

Phase 3, Recruiting
Active & Responsive

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for
Solid Tumor Malignancies, Brain Metastases From Solid Tumors
Location: Dallas TX, Oklahoma City OK, Houston TX, Charleston SC,
Sponsor: A2A Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06136884

Phase 1, Recruiting
Active & Responsive

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX, Louisville KY, Huntersville NC,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06750185

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Dallas PA, Houston TX, Denver CO, Nashville TN,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06619587

Phase 1, Recruiting
Active & Responsive

A Study of TAK-505 in Adults With Solid Tumors

for
Malignant Solid Tumors
Location: Dallas TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07436728

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study of DM005 in Patients With Advanced Solid Tumors

for
Carcinoma, Non-Small-Cell Lung,
Location: Dallas TX, Detroit MI, Fairfax VA
Sponsor: Doma Biopharmaceutical(Suzhou)Co., Ltd.

Sex: All

Age: 18+

Code: NCT06515990

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612176

Phase 1, Recruiting
Active & Responsive

A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06994806

Phase 1, Recruiting
Active & Responsive

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

for
Sjögren, Sjogren Disease, Sjogren's Syndrome
Location: Plano TX, Webster TX, Memphis TN, Orlando FL,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07041099

Phase 1, Recruiting
Active & Responsive

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

for
Focal Onset Seizures
Location: Frisco TX, Houston TX, Little Rock AR, Covington LA,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT06798896

Phase 2, Recruiting
Active & Responsive

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: Carrollton TX, Sugar Land TX, Tuscaloosa AL,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07868419

Phase 3, Recruiting
Active & ResponsiveNew

A Study to Determine the Effect of Access to Multiple Tobacco Flavor Options on Smoking Abstinence Among Primary Cigarette Smokers Using an Electronic Nicotine Delivery System

for
Smoking, Tobacco
Location: Dallas TX, Atlanta GA, Chicago IL, Fort Lauderdale FL,
Sponsor: RAI Services Company

Sex: All

Age: 21 - 65

Code: NCT07879638

Recruiting